Table 1.
Case | DBS lead | Experimental DBS | Chronic DBS | ||||
---|---|---|---|---|---|---|---|
Stim contact (L/R) | Stim Amp (L/R, mA) | Bipolar feedback channel (L/R) | Online filter range (L/R Hz) | Stim Contact (L/R) | Stim Amp (L/R) | ||
1 | Medt1 | L3a | 3 | L24 | 19–25 | L2 | 3.3 V |
2 | Medt1 | L3b/R2c | 3.5/1.5 | L24/R13 | 14–20/15–21 | L1/R2 | 2.9/2.7 mA |
3 | Bost1 | L2c/R3c | 3/2 | L13/R24 | 15–21/14–20 | L2-L3/R2-R3 | 4.0/3.5 mA |
4 | Bost2 | L3c | 1 | L24 | 16–22 | L2-L3 | 4.2 mA |
5 | Abbo | R3a,b | 1.5 | R24 | 17–23 | R2 | 3.2 mA |
6 | Medt2 | R2a | 1.5 | R13 | 19–25 | R1 | 2.6 mA |
7 | Bost3 | L2c/R2c | 2.5/2.5 | L13/R13 | 16–22/22–28 | L2-L4/R2 | 2.8/2.3 mA |
8 | Medt2 | R2c | 3 | R13 | 15–21 | R2 | 3.6 mA |
9 | Medt2 | L3a | 1.5 | L24 | 14–20 | L4 | 2.5 mA |
10 | Medt2 | L2c/R2c | 1/3 | L13/R13 | 22–28/22–28 | L2/R2 | 2.4/3.5 mA |
11 | Medt2 | L3a/R2c | 3.5/3.5 | L24/R13 | 18–24/17–23 | L2/R2 | 1.9/1.7 mA |
12 | Medt2 | L2c/R2c | 3/3 | L13/R13 | 12–18/21–27 | L2/R2 | 1.0/1.0 mA |
13 | Bost1 | L2c/R2c | 2/2 | L13/R13 | 18–24/20–26 | L2-L3/R2-R3 | 4.5/1.7 mA |
Mean | – | – | 2.38 | – | 17.3–23.3 | – | 2.77 |
SEM | – | – | 0.18 | – | 0.66 | – | 0.22 |
Abbo = St. Jude Medical Infinity 0.5 mm spaced directional DBS leads with 1-3-3-1 configuration, Abbott; Amp = amplitude; Bost1 = Vercise™ directional lead with 1-3-3-1 configuration, Boston Scientific; Bost2 = Cartesia™ X leads with 3-3-3-3-3-1 configuration, Boston Scientific; Bost3 = Cartesia™ HX leads with 3-3-3-3-1-1-1-1 configuration, Boston Scientific; DBS = deep brain stimulation; L = left; Medt1 = Quadripolar non-directional Macroelectrode, Model 3389, Medtronic; Medt2 = SenSight™ 0.5 mm spaced directional lead with 1-3-3-1 configuration, Medtronic; R = right; SEM = standard error of the mean; Stim = stimulation.
aThe contacts in experimental and chronic DBS appeared at adjacent levels.
bHemispheres excluded from analysis (see text for detailed reasons).
cThe contacts in experimental and chronic DBS appeared at the same level.